Virinchi Ltd

Virinchi Ltd announced the outcome of its Board of Directors meeting held on August 22, 2026. The board approved the 37th Annual General Meeting (AGM) to be held on September 30, 2026, via Video Conferencing/Other Audio Visual Means. Additionally, the Board approved the Boards Report, Corporate Governance Report, and Management Discussion and Analysis report for the financial year ended March 31, 2026. The reappointment of Mr. Satyanarayana Vedula, Director, who retires by rotation, was also approved.

Virinchi Limited announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board of Directors approved these results during a meeting held on August 13, 2026. The filing includes detailed standalone and consolidated financial statements, segment-wise information, and earnings per share data for the reported period. The company's address and contact details for investor relations are also provided.

Virinchi Limited announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board of Directors approved these results during a meeting held on August 13, 2026. The filing includes detailed standalone and consolidated financial statements, segment-wise information for both standalone and consolidated operations, and earnings per share data for the period. The company provided financial figures for the quarter ended June 30, 2026, along with comparative periods.

Virinchi Ltd has announced that its Board of Directors will convene on August 13, 2026. The primary agenda item is to consider and approve the Un-Audited Standalone & Consolidated Financial Results for the quarter ended June 30, 2026. Concurrently, the trading window for directors, promoters, designated employees, and specified connected persons will be closed until August 15, 2025, in anticipation of the board meeting.

Virinchi Ltd has submitted its report for June 2026 concerning the re-lodgement of transfer requests for physical shares. This report, prepared in accordance with SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated January 30, 2026, was received from the Registrar and Share Transfer Agent, M/s. Aarthi Consultants Private Limited. The company confirms that as of June 2026, there were NIL requests processed and NIL requests received during the month under the special window provided by SEBI. The information is intended for the stock exchanges and general information.

Virinchi Ltd's board of directors met on July 9, 2026, and approved a Business Transfer Agreement (BTA) to acquire the Primary and Secondary Healthcare Business Division operated under the "Bristlecone Hospitals" brand from its subsidiary, Virinchi Health Care Private Limited (VHCPL). This acquisition, effective April 1, 2026, is structured as a slump sale and is subject to shareholder and regulatory approvals. The move aims to establish a dedicated AI-first healthcare platform, allowing Virinchi Hospitals to focus on tertiary and quaternary care and enabling disciplined investment in AI and digital transformation within the healthcare sector.

Virinchi Ltd's board of directors met on July 9, 2026, and approved a Business Transfer Agreement (BTA) to acquire the Primary and Secondary Healthcare Business Division, operating under the "Bristlecone Hospitals" brand, from its subsidiary, Virinchi Health Care Private Limited (VHCPL). This acquisition, effective April 1, 2026, is a slump-sale of the business as a going concern, including related assets, liabilities, and employees. The transaction is considered a related party transaction, to be conducted on an arm's length basis, and requires shareholder approval. The restructuring aims to establish a dedicated AI-first healthcare platform, enabling Virinchi Hospitals to focus on tertiary and quaternary care and positioning Bristlecone Hospitals as a leading AI-enabled community healthcare brand.

Virinchi Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code. The window will be shut for all insiders, including designated persons and their immediate relatives, starting from July 01, 2026. It will remain closed until 48 hours after the declaration of the unaudited financial results for the first quarter ended June 30, 2026. This measure is standard practice to prevent potential insider trading before the official financial results are made public.

Virinchi Ltd has submitted a report regarding the re-lodgement of transfer requests for physical shares, as per SEBI circular dated January 30, 2026. The report, provided by Registrar and Share Transfer Agent M/s. Aarthi Consultants Private Limited, covers the period ended May 2026. The company confirmed that no requests were processed or received during the month under the special window provided by SEBI.

Virinchi Ltd has announced the allotment of 1,50,000 equity shares following the conversion of warrants issued on a preferential basis. The shares were issued at a premium of Rs. 15 each, with an issue price of Rs. 25 per share. The company received Rs. 28,12,500, representing 75% of the issue price, as application money. This allotment increases the company's issued and subscribed share capital to Rs. 1,12,70,73,720.